Found 23 articles for: "treatments"
Clinical Evidence of Skin Improvements With a Biologically Active Multimodal Topical Skin Treatment
September 2026 | Volume 25 | Issue 9 | Original Article | 814 | Copyright © September 2026
Background: Antiaging skin treatments are continuously in development to meet the needs of an aging population and counteract cosmetic effects of glucagon-like peptide-1 receptor...
Read MoreScar Wars: A Review of Topical Scar Therapies
December 2025 | Volume 24 | Issue 12 | Features | 1265 | Copyright © December 2025
Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Editorials | e62 | Copyright © October 2025
Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination Halobetasol Propionate and Tazarotene
August 2025 | Volume 24 | Issue 8 | Original Article | 795 | Copyright © August 2025
Background: Hyperkeratotic plaque psoriasis represents a distinct morphological variant that is difficult to treat with topical therapies because thick lesions may impede the pen...
Read MoreComparative Efficacy of Deucravacitinib and Adalimumab for Scalp Psoriasis: An Indirect Treatment Comparison
August 2025 | Volume 24 | Issue 8 | Original Article | 788 | Copyright © August 2025
Background: Plaque psoriasis of the scalp, a common psoriasis location, remains difficult to manage. The comparative efficacy of newer oral agents, such as deucravacitinib, versus ...
Read MorePrecision, Research, Progress: Updates in the Management of Pityriasis Rubra Pilaris
August 2025 | Volume 24 | Issue 8 | Features | 833 | Copyright © August 2025
Analysis of Therapeutic Interventions for Hypertrophic and Keloid Scarring: A Systematic Review
August 2025 | Volume 24 | Issue 8 | Original Article | 770 | Copyright © August 2025
This systematic review compares the efficacy of pressure garment therapy (PGT) and non-PGT treatments, such as triamcinolone, verapamil, and laser therapies, for hypertrophic and keloid scars. Fo...
Read MoreAddressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions
July 2025 | Volume 24 | Issue 7 | Original Article | 659 | Copyright © July 2025
Female hair loss affects over 50% of postmenopausal women, with up to 40% of healthy women experiencing frontal/parietal hair loss, often beginning around reproductive age. Androgenetic alopecia ...
Read MoreThe Impact on Acne Treatment Regimens if Benzoyl Peroxide-Containing Products are Removed From the Market
June 2025 | Volume 24 | Issue 6 | Features | 586 | Copyright © June 2025
Benzyl peroxide (BPO) has been an important component of many acne treatment regimens. However, an independent testing laboratory, Valisure, filed a Citizen’s Petition with the US Food and ...
Read MorePDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact
June 2025 | Volume 24 | Issue 6 | Original Article | 631 | Copyright © June 2025
Read MoreNeed for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares
June 2025 | Volume 24 | Issue 6 | Case Reports | 634 | Copyright © June 2025
Seborrheic dermatitis is a common chronic inflammatory skin condition historically treated with topical antifungals and anti-inflammatory agents. While topical corticosteroids are frequently used...
Read MoreThe Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma
May 2025 | Volume 24 | Issue 5 | Features | 539 | Copyright © May 2025
Background: Melanoma continues to remain one of the most feared malignancies among patients and dermatologists. Significant strides have been made in expanding the treatment arse...
Read MoreAll Things Acids: A Primer on Alpha Hydroxy, Beta Hydroxy, and Polyhydroxy Acids
May 2025 | Volume 24 | Issue 5 | Features | 549 | Copyright © May 2025
Citation: Vidal SI, Menta N, Friedman A. All things acid: a primer on alpha hydroxy, beta hydroxy, and polyhydroxy acids. J Drugs Dermatol. 2025;24(5):549-548. ...
Read MoreFrom CO2 to Er:YAG: A Comprehensive Review of Laser Treatments for Rhinophyma
November 2024 | Volume 23 | Issue 11 | Original Article | 932 | Copyright © November 2024
Background: Rhinophyma, a benign condition resulting in nasal sebaceous tissue hypertrophy, predominantly affects Caucasian males. There are numerous surgical and medical treatme...
Read MoreEmerging Intralesional Treatments for Plantar Warts: A Systematic Review
December 2022 | Volume 21 | Issue 12 | Original Article | 1322 | Copyright © December 2022
Background: Therapies for plantar warts remain subjective and unclear, which has led to continual pursuit of an optimal treatment. As a consequence, many intralesional therapies have ...
Read MorePersistence With Biologic Treatments in Psoriasis: A Structured Literature Review of Studies Using Administrative Database and Clinical Registry Data
August 2022 | Volume 21 | Issue 8 | Original Article | 881 | Copyright © August 2022
Background: Psoriasis is a chronic, autoimmune-mediated inflammatory disorder. Drug persistence is a composite measure of effectiveness, safety, and treatment satisfaction, often esti...
Read More"I'm Off My Meds": Public Perception of Interactions Between SARS-CoV-2 Vaccines and Anti-Psoriatic Treatments Online
August 2022 | Volume 21 | Issue 8 | Features | 901 | Copyright © August 2022
Importance: Psoriasis patients may seek information about the SARS-CoV-2 vaccine and their diagnosis from social media platforms. Analyses of social media interactions may help guide dermatologists&rs...
Read MoreEffective and Safe Repeated Full-Face Treatments With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin Boosting Hyaluronic Acid
July 2019 | Volume 18 | Issue 7 | Original Article | 682 | Copyright © July 2019
Background: It is important to study full-face aesthetic combination treatments to establish well-founded individual treatment plans.
Ob...
Read MoreManagement of Rosacea-Prone Skin: Evaluation of a Skincare Product Containing Ambophenol, Neurosensine, and La Roche-PosayThermal Spring Water as Monotherapy or Adjunctive Therapy
August 2013 | Volume 12 | Issue 8 | Original Article | 920 | Copyright © August 2013
OBJECTIVE: The objective of these studies was to investigate whether a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay thermal spring water formulated in a highly protective p...
Read MoreEfficacy and Safety of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of Two Randomized, Double-blind, and Vehicle-Controlled Pivotal Studies
June 2013 | Volume 12 | Issue 6 | Original Article | 650 | Copyright © June 2013
BACKGROUND: Brimonidine tartrate, a highly selective α2-adrenergic receptor agonist with potent vasoconstrictive activity, was shown to reduce erythema of rosacea.
OBJECTIVE: To assess the ...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
